[1]
M. Basile, L. Somaini, and A. Cicchetti, “Budget Impact Analysis of prolonged-release buprenorphine depot-formulation for the management of patients affected by opioid use disorder”, Grhta, vol. 8, no. 1, pp. 96–104, Jul. 2021.